Medlab Middle East looks to the future of laboratories as the market is estimated to reach USD473.84 million by 2029

The medical laboratory market in the Middle East and Africa (MEA) is expected to grow rapidly in the coming years, with the market size projected to reach USD 473.84 million by 2029 at a Compound Annual Growth Rate (CAGR) of 12.6%. Against this positive background, Medlab Middle East, which will take place from 3-6 February, will gather medical laboratory professionals and industry leaders to explore the future of laboratories and their role in transforming healthcare in the region and beyond.

The medical laboratory market is a critical segment of the healthcare sector that offers a wide array of diagnostic and testing services. Laboratories are central to the identification, monitoring, and management of diseases, as well as the development of treatment plans that healthcare providers can use to offer the best possible care to their patients.

Over the past few years, the demand for healthcare services in the MEA region has increased substantially due to rising incidence of chronic and non-communicable diseases, population pressure and government-sponsored healthcare and insurance programs.

"Now in its 24th edition, Medlab Middle East is the leading event for laboratory technology and innovation, and a platform for global leaders, pioneers and experts in the industry to meet," said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.

Lab medicine helps healthcare providers gain a more holistic view of a patient’s health by improving access to health information and enabling people to take more control of their health. These technologies are driving faster, more accurate and more personalized diagnosis and treatments, reducing costs, increasing accessibility and enhancing outcomes.

Technology has made tremendous progress in the last few years to transform healthcare and the way doctors diagnose and treat diseases. Some of the most significant advancements include Next Generation Sequencing (NGS), Point of Care Testing (POCT), and 3D Printing. Artificial intelligence (AI) and machine learning have also transformed medical lab technology by integrating data analytics and prediction algorithms to enhance diagnosis and care.

Medlab Middle East will feature the latest products from leading laboratory brands including Abbott, Beckman Coulter, Coulter and Randox; and will offer 12 CME-accredited conference tracks at the Medlab Middle East Congress. The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre.

Dubai, United Arab Emirates: The medical laboratory market in Middle East and Africa (MEA) is expected to grow at a CAGR of 12.6% from 2023 to 2029, with the market size projected to reach $473.84 million by 2029. Against this positive background, Medlab Middle East, which will take place from 3-6 February, will gather medical laboratory professionals and industry leaders to explore the future of laboratories and their role in transforming healthcare in the region and beyond.

The medical laboratory market is a critical segment of the healthcare sector that offers a wide array of diagnostic and testing services. Laboratories are central to the identification, monitoring, and management of diseases, as well as the development of treatment plans that healthcare providers can use to offer the best possible care to their patients.

Over the past few years, the demand for healthcare services in the MEA region has increased substantially due to rising incidence of chronic and non-communicable diseases, population pressure and government-sponsored healthcare and insurance programs.

"Now in its 24th edition, Medlab Middle East is the leading event for laboratory technology and innovation, and a platform for global leaders, pioneers and experts in the industry to meet," said Tom Coleman, Group Exhibition Director, Informa Markets Healthcare.

Lab medicine helps healthcare providers gain a more holistic view of a patient’s health by improving access to health information and enabling people to take more control of their health. These technologies are driving faster, more accurate and more personalized diagnosis and treatments, reducing costs, increasing accessibility and enhancing outcomes.

Technology has made tremendous progress in the last few years to transform healthcare and the way doctors diagnose and treat diseases. Some of the most significant advancements include Next Generation Sequencing (NGS), Point of Care Testing (POCT), and 3D Printing. Artificial intelligence (AI) and machine learning have also transformed medical lab technology by integrating data analytics and prediction algorithms to enhance diagnosis and care.

Medlab Middle East will feature the latest products from leading laboratory brands including Abbott, Beckman Coulter, Coulter and Randox; and will offer 12 CME-accredited conference tracks at the Medlab Middle East Congress. The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre.

Medlab Middle East, the region's largest medical laboratory exhibition and congress, is crucial in enhancing the status of laboratory medicine globally and contributing to the development of diagnostics by providing an international platform for laboratory industry leaders, including manufacturers, distributors and dealers.

Medlab Middle East was created from 15 years of growth alongside the largest healthcare event in the MENA region, Arab Health. Now in its 24th year, this annual medical laboratory meeting brings together over 180 countries’ exhibitors and attendees.

Medlab Middle East will take place from 3 – 6 February 2025 at the Dubai World Trade Centre, Dubai, UAE. A digital event will occur from 4 December – 20 February 2025.